Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

4 Stocks: ACAD, I, IDRA, VKTX

Published 10/17/2018, 12:14 AM
Updated 07/09/2023, 06:31 AM

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), which I put out as a swing on Tuesday, because this stock has been very toppy. A longer-term pattern shows a big run-up that took this from under a dollar in 2010-11, all the way up to over 50 in 2015. After a massive, multi-year top, it came down, broke support to below 12, and snapped back sharply. The current pattern shows that the declining topsline and channel were taken out with a super surge, it consolidated for about 2 1/2 weeks, and on Tuesday it popped 1.64, or 7.7%, to 22.92, on 3.7 million shares. With the increase in volume at 3.7 million shares, and the OBV holding up steadily, it’s slightly moving up. I think it may start to accelerate. Minor resistance is at the 26-28 zone, which is my target zone. Once it gets through there, I’m looking at 32 and 33.

Intelsat S.A. (NYSE:I) is a monster stock. Ever since we first spotted it running in the 3-4 range, it’s now at 36 plus. On Tuesday, it was up a whopping 4.14, or 13%, to 36.58, on 5.4 million shares. It broke out of the pattern it was in, and I’m looking for an extension that takes it to 42.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) gained 68 cents, or 8.44%, to 8.74, on 226,651 shares traded. The swing trade we put on it around 6.19-.20, ran up, pulled back, popped, and formed a large wedge. It looks like waves one and two are completed and wave three should take it to 12 1/2-13, which is my next target.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Viking Therapeutics, Inc. (NASDAQ:VKTX), which had a big explosive move and pullback, kept drifting lower. On Tuesday, I believe, it popped out, advancing 1.06, or 7.46%, to 15.26, on 3.9 million shares, closing at the upper end of the range. But the volume wasn’t heavy enough. I want to see volume that is in the 6, 7, 10 million range. There’s resistance around 16 3/4. That will be my next target, if it follows through. If it does, I’m looking for 16 3/4 and 18 1/4 going forward.

Stocks on the long side included ACADIA Pharmaceuticals Inc. (ACAD), Aldeyra ACAD, AMRN, I, IDRA, Viking Therapeutics, Inc. (VKTX) Therapeutics, Inc. (NASDAQ:ALDX), Amarin Corporation plc (NASDAQ:AMRN), Blink Charging Co. (NASDAQ:BLNK), Boston Scientific Corporation (NYSE:BSX), CareDx, Inc (NASDAQ:CDNA), Cerus Corporation (NASDAQ:CERS), CryoLife, Inc. (NYSE:CRY), FireEye, Inc. (NASDAQ:FEYE), Guardant Health, Inc. (NASDAQ:GH), GOL Linhas Aéreas Inteligentes S.A. (NYSE:GOL), Intelsat S.A. (I), Idera Pharmaceuticals, Inc. (IDRA), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Noodles & Company (NASDAQ:NDLS), NIO Inc. (NYSE:NIO), PagSeguro Digital Ltd. (NYSE:PAGS), Tesaro, Inc. (NASDAQ:TSRO), and Viking Therapeutics, Inc. (NASDAQ:VKTX).

Watch video here.

Latest comments

looking for the next monster stock like I. Any lie that? wow!
Any Like that? (no editing messages!)
How do you know that? And where did you get those information and did u check to last 7 years charts?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.